Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | RLAY | DFTX | ||
| Company | Enliven Therapeutics Inc | Relay Therapeutics Inc | Definium Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 59.09 | 20.12 | 47.51 | ||
| High | 60.38 | 20.48 | 47.55 | ||
| Low | 57.68 | 19.77 | 42.42 | ||
| Last | 57.92 | 20.07 | 42.79 | ||
| Change | -0.86 | +0.08 | +1.88 | ||
| Percent Change | -1.46% | +0.40% | +4.60% | ||
| Volume | 1,010,900 | 1,610,900 | 7,635,600 | ||
| 20-Day Average Volume | 1,052,550 | 2,211,500 | 2,140,790 | ||
| Previous | 58.78 | 19.99 | 40.91 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.63 | 19.28 | 43.52 | ||
| 20-Day Raw Stochastic | 65.52% | 78.67% | 26.57% | ||
| 20-Day Relative Strength | 61.38 | 60.65 | 54.01 | ||
| Weighted Alpha | +91.56 | +380.03 | +186.46 | ||
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.98% since 08/05/26 | +1.93% since 08/05/26 | -3.60% since 08/05/26 | ||
| Low | 57.39 on 08/11/26 | 18.67 on 08/07/26 | 40.62 on 08/11/26 | ||
| High | 61.86 on 08/06/26 | 20.71 on 08/10/26 | 49.70 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | +13.37% since 07/10/26 | +0.32% since 07/10/26 | -9.09% since 07/10/26 | ||
| Low | 49.56 on 07/17/26 | 17.71 on 07/28/26 | 40.29 on 07/28/26 | ||
| High | 62.32 on 08/05/26 | 20.71 on 08/10/26 | 49.70 on 08/07/26 | ||
| 3-Month | |||||
| %Chg | +36.93% since 05/12/26 | +55.22% since 05/12/26 | +102.22% since 05/12/26 | ||
| Low | 33.45 on 06/08/26 | 11.62 on 05/20/26 | 19.33 on 05/19/26 | ||
| High | 62.32 on 08/05/26 | 20.79 on 07/09/26 | 49.70 on 08/07/26 | ||
| 6-Month | |||||
| %Chg | +113.25% since 02/12/26 | +127.81% since 02/12/26 | +163.65% since 02/12/26 | ||
| Low | 25.29 on 02/20/26 | 8.42 on 02/20/26 | 15.61 on 02/13/26 | ||
| High | 62.32 on 08/05/26 | 20.79 on 07/09/26 | 49.70 on 08/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,306,870 | 4,380,648 | 4,078,645 | ||
| Shares Outstanding, K | 73,271 | 219,142 | 99,698 | ||
| Annual Sales, $M | 0 | 15,360,000 | 0 | ||
| Annual Net Income, $M | -103,690,000 | -276,480,000 | -183,790,000 | ||
| Last Qtr Sales, $M | 0 | 350,000 | 0 | ||
| Last Qtr Income, $M | -32,490,000 | -83,710,000 | -158,990,000 | ||
| 60-Month Beta | 0.27 | 1.69 | 2.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/05/26 | -0.41 on 08/06/26 | -1.44 on 08/06/26 | ||
| Latest Earnings Date | 11/11/26 | 11/05/26 | 11/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||